Announcement PDF Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 1 / 8 Announcement Summary Entity name IMAGION BIOSYSTEMS LIMITED Announcement Type New announcement Date of this announcement Tuesday September 01, 2026 The +securities to be quoted are: Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue. Number of listed securities issued to the lead manager that were not approved by shareholders but are due under the lead manager mandate connected with the placement announced on 25 June 2026. Total number of +securities to be quoted ASX +security code Security description Number of +securities to be quoted Issue date IBXO OPTION EXPIRING 13-DEC-2027 7,500,000 31/08/2026 Refer to next page for full details of the announcement Other Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 2 / 8 Part 1 - Entity and announcement details 1.1 Name of entity IMAGION BIOSYSTEMS LIMITED We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules. 1.2 Registered number type ACN Registration number 616305027 1.3 ASX issuer code IBX 1.4 The announcement is 1.5 Date of this announcement 1/9/2026 New announcement Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 3 / 8 Part 2 - Type of Issue 2.1 The +securities to be quoted are: Please refer to the response to Q2.3d for further information about the type of securities to be quoted and the circumstances of the issue. 2.2 The +class of +securities to be quoted is: 2.3c Have these +securities been offered under a +disclosure document or +PDS? 2.3d Please provide any further information needed to understand the circumstances in which you are applying to have these +securities quoted on ASX, including why the issue of the +securities has not been previously announced to the market in an Appendix 3B Number of listed securities issued to the lead manager that were not approved by shareholders but are due under the lead manager mandate connected with the placement announced on 25 June 2026. 2.4 Any on-sale of the +securities to be quoted within 12 months of their date of issue will comply with the secondary sale provisions in sections 707(3) and 1012C(6) of the Corporations Act by virtue of: The publication of a cleansing notice under section 708A(5), 708AA(2)(f), 1012DA(5) or 1012DAA(2)(f) No Additional +securities in a class that is already quoted on ASX ("existing class") Other Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 4 / 8 Part 3B - number and type of +securities to be quoted (existing class) where issue has not previously been notified to ASX in an Appendix 3B Additional +securities to be quoted in an existing class ASX +security code and description IBXO : OPTION EXPIRING 13-DEC-2027 Issue date 31/8/2026 Will the +securities to be quoted rank equally in all respects from their issue date with the existing issued +securities in that class? Issue details Number of +securities to be quoted 7,500,000 Are the +securities being issued for a cash consideration? Please describe the consideration being provided for the +securities Issued to CPS Capital Group as part consideration for lead manager services provided in connection with the placement announced 25/06/26. Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted 0.010000 Any other information the entity wishes to provide about the +securities to be quoted The purpose(s) for which the entity is issuing the securities To pay for services rendered Please provide additional details Issued to CPS Capital Group as part consideration for lead manager services provided in connection with the placement announced 25/06/26. No Yes Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 5 / 8 Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 6 / 8 Part 4 - Issued capital following quotation Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise: The figures in parts 4.1 and 4.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing. 4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application) ASX +security code and description Total number of +securities on issue IBXO : OPTION EXPIRING 13-DEC-2027 490,833,357 IBX : ORDINARY FULLY PAID 801,006,908 4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX) ASX +security code and description Total number of +securities on issue IBXAAY : PERFORMANCE RIGHTS CLASS A 975,000 IBXAAZ : PERFORMANCE RIGHTS CLASS B 375,000 IBXAAV : OPTION EXPIRING 28-FEB-2029 EX $0.64 75,000 IBXABB : OPTION EXPIRING 10-SEP-2027 EX $0.04284 12,254,902 IBXAAX : OPTION EXPIRING 29-MAY-2027 EX $0.11284 2,048,122 IBXAAQ : CONVERTIBLE NOTES 2,780,000 IBXABA : PERFORMANCE RIGHTS CLASS C 500,000 IBXAA : OPTION EXPIRING 21-SEP-2028 EX $0.04 26,250,000 IBXABF : OPTION EXPIRING 23-APR-2029 EX $0.0297 10,600,177 IBXABD : OPTION EXPIRING 29-MAY-2028 EX $0.019 2,000,000 IBXABE : OPTION EXPIRING 29-MAY-2030 EX $0.012 4,700,000 IBXAAB : OPTION EXPIRING 01-MAY-2027 EX $1.12 68,750 IBXAAC : OPTION EXPIRING 01-MAY-2028 EX $1.12 50,000 Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 7 / 8 IBXAAM : OPTION EXPIRING VARIOUS DATES EX $1.68 21,775 IBXAF : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 3,125,000 IBXAG : PERFORMANCE RIGHTS CLASS D 2,200,000 IBXAH : PERFORMANCE RIGHTS CLASS E 4,000,000 IBXAAH : PERFORMANCE OPTION EXPIRING VAR DATES EX $3.488 100,000 Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 8 / 8 Part 5 - Other Listing Rule requirements 5.1 Are the +securities being issued under an exception in Listing Rule 7.2 and therefore the issue does not need any security holder approval under Listing Rule 7.1? 5.2 Has the entity obtained, or is it obtaining, +security holder approval for the issue under listing rule 7.1? 5.2b Are any of the +securities being issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1? 5.2b.1 How many +securities are being issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1? 7500000 5.2c Are any of the +securities being issued without +security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A (if applicable)? No Yes No No